\
&
Contact us
\
&
Contact us
The administrative and financial framework with rules for application and project implementation of Horizon 2020 call are set-out in the Grant Agreement; the Annotated Model Grant Agreement explains extensively all details.
The European commission gives on a regular basis trainings with background information on coordinators' days, that can be followed live or through webstreaming. Presentations can be consulted in the documents in below.
Information on specific legal and financial topics are listed and documented in the documents in below.
ann.vanhauwaert@fwo.be
+32 2 550 15 60
Ria.debreucker@vlaio.be
+32 2 553 13 77
Find the contact info on the site of WEWIS
The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.
The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
